Gut Liver.  2009 Jun;3(2):95-100. 10.5009/gnl.2009.3.2.95.

Prevalence of Subjects at a High or Very High Risk of Gastric Cancer in Japan

Affiliations
  • 1Department of Healthcare, Social Insurance Shiga Hospital, Otsu, Japan. shigemin@rainbow.plala.or.jp

Abstract

BACKGROUND/AIMS
The presence of Helicobacter pylori (H. pylori) infection represents a high-risk state of gastric cancer, but the risk is even higher in gastric atrophy. H. pylori stool antigen (HpSA) and serum pepsinogen (PG) tests are useful tools for screening present infection and gastric atrophy, respectively. To determine the prevalence of subjects at a high risk (HpSA+ or PG+) or very high risk (PG+) of gastric cancer in Japan, we applied the two tests to a general population.
METHODS
The subjects included 311 volunteers. We used Meridian HpSA ELISA for the HpSA test and Pepsinogen RIA Beads for the PG test. PG I at < or =70 microgram/L and I/II ratio of < or =3.0 were used as cutoffs for PG-test positivity.
RESULTS
Positivity rates in HpSA and PG tests significantly increased with age in those younger than 60 years and in all age groups, respectively. The proportions of HpSA-/PG- and HpSA+/PG+ subjects decreased and increased with age, respectively. A small proportion of HpSA-/PG+ subjects were older than 40 years. The prevalence of subjects who were either HpSA+ or PG+ increased with age (>50% of those older than 40 years). Half of the subjects older than 60 years were PG+.
CONCLUSIONS
In Japan, more than 50% of general population aged > or =40 years is at a high risk of gastric cancer, and half of the population aged > or =60 years is at a very high risk.

Keyword

Helicobacter pylori; Stool antigen; Pepsinogen; Gastric cancer screening; Epidemiology

MeSH Terms

Aged
Atrophy
Enzyme-Linked Immunosorbent Assay
Helicobacter pylori
Humans
Japan
Mass Screening
Pepsinogen A
Prevalence
Stomach Neoplasms
Pepsinogen A
Full Text Links
  • GNL
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr